A detailed history of Ameritas Investment Partners, Inc. transactions in Regenxbio Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 4,037 shares of RGNX stock, worth $29,873. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,037
Previous 4,037 -0.0%
Holding current value
$29,873
Previous $47,000 10.64%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$16.46 - $19.99 $17,217 - $20,909
1,046 Added 34.97%
4,037 $66,000
Q1 2020

May 13, 2020

BUY
$21.5 - $54.2 $3,225 - $8,130
150 Added 5.28%
2,991 $97,000
Q2 2019

Aug 14, 2019

BUY
$42.0 - $59.29 $9,912 - $13,992
236 Added 9.06%
2,841 $146,000
Q3 2018

Nov 13, 2018

BUY
$65.0 - $82.15 $14,430 - $18,237
222 Added 9.32%
2,605 $197,000
Q2 2018

Aug 13, 2018

SELL
$27.2 - $74.35 $897 - $2,453
-33 Reduced 1.37%
2,383 $171,000
Q2 2017

Aug 15, 2017

BUY
N/A
2,416
2,416 $48,000

Others Institutions Holding RGNX

About REGENXBIO Inc.


  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $320M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Ameritas Investment Partners, Inc. Portfolio

Follow Ameritas Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.